MULTIMODAL IMAGING IN DEFEROXAMINE-RELATED OCULAR TOXICITY: RAPID DEVELOPMENT DUE TO SUPRATHERAPEUTIC DOSING AND PROGRESSION DESPITE DOSE REDUCTION.

Huynh EM, Khan M, Ren Y, Orlin A, Kiss S, Botsford BW

DOI: 10.1097/icb.0000000000001746
Published: 2026 May 1
Container: Retinal cases & brief reports
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/icb.0000000000001746,
  title = {MULTIMODAL IMAGING IN DEFEROXAMINE-RELATED OCULAR TOXICITY: RAPID DEVELOPMENT DUE TO SUPRATHERAPEUTIC DOSING AND PROGRESSION DESPITE DOSE REDUCTION.},
  author = {Huynh EM and Khan M and Ren Y and Orlin A and Kiss S and Botsford BW},
  year = {2026},
  journal = {Retinal cases \& brief reports},
  doi = {10.1097/icb.0000000000001746},
  url = {https://doi.org/10.1097/icb.0000000000001746}
}

RIS

TY  - JOUR
TI  - MULTIMODAL IMAGING IN DEFEROXAMINE-RELATED OCULAR TOXICITY: RAPID DEVELOPMENT DUE TO SUPRATHERAPEUTIC DOSING AND PROGRESSION DESPITE DOSE REDUCTION.
AU  - Huynh EM
AU  - Khan M
AU  - Ren Y
AU  - Orlin A
AU  - Kiss S
AU  - Botsford BW
PY  - 2026
JO  - Retinal cases & brief reports
DO  - 10.1097/icb.0000000000001746
UR  - https://doi.org/10.1097/icb.0000000000001746
ER  -

APA

EM, H., M, K., Y, R., A, O., S, K., & BW, B. (2026). MULTIMODAL IMAGING IN DEFEROXAMINE-RELATED OCULAR TOXICITY: RAPID DEVELOPMENT DUE TO SUPRATHERAPEUTIC DOSING AND PROGRESSION DESPITE DOSE REDUCTION.. Retinal cases & brief reports. https://doi.org/10.1097/icb.0000000000001746

Source records

pubmed · retrieved 2026-09-26T09:46:48.104Z